natgillin/translations-raw huggingface dataset:
Filgrastim ratiopharm 30 MIU/0.5 ml solution for injection or infusion Filgrastim ratiopharm 48 MIU/0.8 ml solution for injection or infusion
Filgrastim ratiopharm 30 000 k.i.e./0,5 ml raztopina za injiciranje ali infundiranje Filgrastim ratiopharm 48 000 k.i.e./0,8 ml raztopina za injiciranje ali infundiranje
Filgrastim ratiopharm 30 MIU/0.5 ml: Each pre-filled syringe contains 30 million international units [MIU] (300 microgram) of filgrastim in 0.5 ml solution.
Filgrastim ratiopharm 30 000 k.i.e./0,5 ml: ena napolnjena injekcijska brizga vsebuje 30 milijonov mednarodnih enot [i.e.] (300 mikrogramov) zdravila filgrastim v 0,5 ml raztopine.
Filgrastim ratiopharm 48 MIU/0.8 ml
Filgrastim ratiopharm 48 000 k.i.e./0,8 ml
Filgrastim ratiopharm 48 MIU/0.8 ml solution for injection or infusion
Filgrastim ratiopharm 48 000 k.i.e./0,8 ml raztopina za injiciranje ali infundiranje
Filgrastim ratiopharm 48 MIU/0.8 ml solution for injection or infusion Filgrastim
Filgrastim ratiopharm 48 000 k.i.e./0,8 ml raztopina za injiciranje ali infundiranje Filgrastim
Filgrastim ratiopharm and bone marrow transplantation
Zdravilo Filgrastim ratiopharm in presaditev kostnega mozga
Filgrastim ratiopharm and chemotherapy
Zdravilo Filgrastim ratiopharm in kemoterapija
Filgrastim ratiopharm and neutropenia in patients with HIV infection
Zdravilo Filgrastim ratiopharm in nevtropenija pri bolnikih, okuženih s HIV
Filgrastim ratiopharm and peripheral blood stem cell mobilisation
Zdravilo Filgrastim ratiopharm in zbiranje matičnih celic iz periferne krvi
Filgrastim ratiopharm and severe chronic neutropenia
Zdravilo Filgrastim ratiopharm in huda kronična nevtropenija
Filgrastim ratiopharm is a solution for injection or infusion in a pre-filled syringe.
Zdravilo Filgrastim ratiopharm je raztopina za injiciranje ali infundiranje v napolnjeni injekcijski brizgi.
Filgrastim ratiopharm is a ‘biosimilar’ medicine.
Zdravilo Filgrastim ratiopharm je podobno biološko zdravilo.
Filgrastim ratiopharm is used to stimulate the production of white blood cells in the following situations:
Zdravilo Filgrastim ratiopharm se uporablja za spodbujanje tvorbe belih krvničk v naslednjih primerih:
Filgrastim ratiopharm is usually given in a specialised treatment centre, although patients who receive it by injection under the skin may inject themselves once they have been trained appropriately.
Zdravilo Filgrastim ratiopharm se običajno daje v specializiranem zdravstvenem centru,
Filgrastim ratiopharm should not be used in people who may be hypersensitive (allergic) to filgrastim or any of the other ingredients.
Zdravila Rebetol se ne sme uporabljati pri ljudeh, ki utegnejo biti preobčutljivi za (alergični na) filgrastim ali katero koli drugo sestavino zdravila.
Filgrastim ratiopharm treatment will last for 4 to 5 days.
Zdravljenje z zdravilom Filgrastim ratiopharm bo trajalo 4 do 5 dni.
Filgrastim ratiopharm was studied to show that it is comparable to the reference medicine, Neupogen.
Zdravilo Filgrastim ratiopharm so preučevali, da bi dokazali, da je podobno referenčnemu zdravilu Neupogen.
Filgrastim should be diluted in 20 ml of 5% glucose solution (see section 6.6).
Filgrastim je treba razredčiti v 20 ml 5 % raztopine glukoze (glejte poglavje 6.6).
Filgrastim should be diluted in 20 ml of 50 mg/ml (5%) glucose solution for infusion (see section 6.6).
Filgrastim je treba razredčiti z 20 ml 50 mg/ml (5 %) raztopine glukoze za infundiranje (glejte poglavje 6.6).
Filgrastim should be diluted in 20 mL of glucose 50 mg/mL (5 %) solution for infusion (see section 6.6 for instructions on dilution).
Filgrastim je potrebno razredčiti v 20 ml glukoze 50 mg/ml (5 %) raztopini za infundiranje (postopek redčenja je opisan v poglavju 6.6).
Filgrastim should be diluted in 20 ml of glucose 50 mg/ml (5%) solution for infusion (see section 6.6 for instructions on dilution).
Filgrastim je potrebno razredčiti v 20 ml glukoze 50 mg/ml (5%) raztopini za infundiranje (postopek redčenja je opisan v poglavju 6.6).
Filgrastim should be discontinued and appropriate treatment given.
V takšnih primerih je treba zdravljenje s filgrastimom prenehati in uvesti ustrezno zdravljenje.
Filgrastim should be given by subcutaneous injection.
Filgrastim se daje v obliki subkutane injekcije.
Filgrastim should be permanently discontinued in patients who experience a serious allergic reaction.
V primeru resne alergijske reakcije je treba zdravljenje s filgrastimom dokončno ukiniti.
Filgrastim should be permanently discontinued in patients who experience a serious allergic reaction.
Zdravljenje s filgrastimom je treba dokončno ukiniti pri tistih bolnikih, ki imajo resno alergijsko reakcijo.
Filgrastim should not be administered to patients with severe congenital neutropenia who develop leukaemia or have evidence of leukaemic evolution.
Filgrastima se ne sme dajati bolnikom s hudo prirojeno nevtropenijo, pri katerih se razvije levkemija ali pri katerih obstajajo znaki evolucije levkemije.
Filgrastim should not be administered to patients with severe congenital neutropenia who develop leukaemia or have evidence of leukaemic evolution.
Filgrastima se ne sme uporabljati pri bolnikih s hudo prirojeno nevtropenijo, pri katerih se razvije levkemija ali pri katerih obstajajo dokazi levkemične evolucije.
Filgrastim should not be used to increase the dose of cytotoxic chemotherapy beyond established dosage regimens (see below).
Filgrastima se ne sme uporabljati za povečevanje odmerka citotoksične kemoterapije preko odmerkov iz uveljavljenih načinov odmerjanja (glejte spodaj).
Filgrastim should not be used to increase the dose of cytotoxic chemotherapy beyond established dosage regimens.
Filgrastima se ne sme uporabljati za povečevanje odmerka citotoksične kemoterapije preko uveljavljenih shem odmerjanja.
Filgrastim should not be used to increase the dose of cytotoxic chemotherapy beyond established dosage regimens.
Zdravilo Filgrastim se ne sme uporabljati za povečanje odmerka citotoksične kemoterapije zunaj uveljavljenih shem odmerjanja.
Filgrastim was studied in repeated dose toxicity studies up to 1 year in duration which revealed changes attributable to the expected pharmacological actions including increases in leukocytes, myeloid hyperplasia in bone marrow, extramedullary granulopoiesis and splenic enlargement.
Filgrastim so preučevali v konvencionalnih študijah toksičnosti pri ponavljajočih odmerkih, ki so trajale do 1 leta in pri katerih so razkrili spremembe, ki jih je bilo mogoče pripisati pričakovanim farmakološkim učinkom vključno z zvišanjem števila levkocitov, mieloidno hiperplazijo v kostnem mozgu, ekstramedularno hematopoezo in zvečanjem vranice.
Filgrastim works by encouraging the bone marrow to produce more white blood cells, increasing white blood cell counts and treating neutropenia.
Filgrastim deluje tako, da spodbuja kostni mozeg, da proizvaja več belih krvnih celic, s čimer se število belih krvničk poveča in se zdravi nevtropenija.
Fill line
oznaka najmanjše polnitve
Fill out the analysis request form with the patient details on the left hand side of the form and the doctor’s name and address on the right hand side.
Izpolnite obrazec za naročilo analize z bolnikovimi podatki na levi strani obrazca ter z imenom in naslovom zdravnika na desni strani.
Fill the 13C-urea jar to the brim with water for a second and third time and add these contents to the drinking glass (total volume of tap water should be approximately 30 ml).
Lonček do roba napolnite z vodo še drugič in tretjič in dodajte to vsebino v kozarec (celotna količina vode mora biti približno 30 ml).
Fill the dosing scoop to the top.
Merico za odmerjanje napolnite do vrha.
Fill the dosing scoop up to the “½ line” on the side (see Figure C).
Napolnite merico za odmerjanje do črte “1/2” ob strani (glejte sliko C).
Fill the measuring cup to the graduation mark(s) corresponding to your prescribed dose.
Napolnite merico do graduacijske oznake, ki ustreza predpisanemu odmerku.
Fill the mixing cup with drinking water.
Posodico za mešanje napolnite s pitno vodo.
Fill the oral dispenser with the prescribed dose from the mixing cup according to the table above.
Odmernik napolnite s predpisanim odmerkom iz čaše za mešanje glede na zgornjo preglednico.
Fill the oral syringe with a small amount of solution by pulling the plunger down (figure 5A),
Napolnite peroralno brizgo z majhno količino raztopine, tako da izvlečete bat navzdol (slika 5A).
Fill the syringe
Napolnite brizgo
Fill the syringe
Napolnite injekcijsko brizgo
Fill the syringe with air by pulling the plunger back to the level that represents your dose as prescribed by your doctor.
Povlecite bat in napolnite brizgo z zrakom do oznake, ki predstavlja odmerek, ki vam ga je predpisal zdravnik.
Fill the syringe with the liquid by pulling the piston to the graduation mark corresponding to the quantity in millilitre (ml) prescribed by your doctor.
Napolnite brizgo s tekočino, tako da vlečete bat navzdol do oznake, ki ustreza količini v mililitrih (ml), ki vam jo je predpisal zdravnik.
Fill up the measuring device containing the water with the calculated volume of the product to obtain the predilution.
Dopolnite merilno napravo, v kateri je voda, z izračunanim volumnom zdravila, da dobite predraztopino.
Fill up the second sample tube (Label “Sampling time: 00-minute-value”) with breath by following the same procedure.
Napolnite drugo epruveto (oznaka "Čas vzorčenja: 00-minutna vrednost") z izdihanim zrakom po enakem postopku.
filled syringe
napolnjena
filled syringe (glass)
injekcijska brizga
filled syringe (glass)
napolnjena
filled syringe +
napolnjena
Filled volumes of the vials are: 0.3 ml, 0.45 ml, 0.7 ml and 1.0 ml
Napolnjeni volumni vial so: 0,3 ml, 0,45 ml, 0,7 ml in 1,0 ml
Film coat: hypromellose, titanium dioxide (E171), lactose monohydrate, triacetin, indigo carmine aluminium lake (E132)
Filmska obloga: hipromeloza, titanov dioksid (E171), laktoza monohidrat, triacetin, indigotin (E132).
Film coat: lactose monohydrate (see section 2), hypromellose (E464), titanium dioxide (E171), triacetin, red iron oxide (E172).
Filmska obloga: laktoza monohidrat (glejte poglavje 2), hipromeloza (E464), titanov dioksid (E171), triacetin, rdeči železov oksid (E172).
Film coat: lactose monohydrate (see section 2), hypromellose (E464), titanium dioxide (E171), triacetin, yellow iron oxide (E172)
Filmska obloga: laktoza monohidrat (glejte poglavje 2), hipromeloza (E464), titanov dioksid (E171), triacetin, rumeni železov oksid (E172).
Film coat: poly(vinyl alcohol), titanium dioxide (E171), macrogol 3350, talc.
Filmska obloga: poli(vinilalkohol), titanov dioksid (E171), makrogol 3350, smukec.
Film coated tablet
filmsko obložena tableta
Film coated tablet.
Filmsko obložena tableta
Film coated tablets
Filmsko obložene
Film coated tablets
Filmsko obložene tablete
Film coated tablets
Filsko obložene tablete
Film coated tablets.
filmsko obložena tableta
Film coating (2 mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg tablets) Hypromellose 2910, talc, Macrogol 8000, titanium dioxide (E171), colourants*
Filmska obloga (2 mg, 4 mg, 6 mg, 8 mg, 10 mg in 12 mg tablete): hipromeloza 2910, smukec, makrogol 8000, titanov dioksid (E171), barvila
Film coating Betmiga 25 mg prolonged-release tablets Hypromellose
Filmska obloga Betmiga 25 mg tablete s podaljšanim sproščanjem hipromeloza
Film coating Betmiga 50 mg prolonged-release tablets Hypromellose
Filmska obloga Betmiga 50 mg tablete s podaljšanim sproščanjem hipromeloza
Film coating for 300 mg/25 mg strength: Hypromellose
Filmska obloga za jakost 300 mg/25 mg: hipromeloza
Film coating Hypromellose (E464) Titanium dioxide (E171) Macrogol 400
Filmska obloga: hipromeloza (E464) titanov dioksid (E171) makrogol 400
Film coating: Hypromellose (E464), lactose monohydrate, titanium dioxide (E171), triacetin (E1518), polyethylene glycol (E1521).
Filmska obloga: hipromeloza (E464), laktoza monohidrat, titanov dioksid (E171), triacetin (E1518), polietilenglikol (E1521).
Film coating: hypromellose, macrogol 400, titanium dioxide (E171), talc.
Filmska obloga: hipromeloza, makrogol 400, titanov dioksid (E171), smukec.
Film coating: hypromellose, titanium dioxide (E171), talc, propylene glycol.
Filmska obloga: hipromeloza, titanov dioksid (E171), smukec, propilenglikol.
Film coating: hypromellose, titanium dioxide (E171), triacetin, iron oxide yellow (E172)
Filmska obloga: hipromeloza, titanov dioksid (E171), triacetin, rumeni železov oksid (E172)
Film coating: methacrylic acid-ethyl acrylate copolymer (1:1),sodium laurilsulfate, polysorbate 80, talc (E553b), triacetin, simeticone.
Filmska obloga: kopolimer metakrilne kisline in etilakrilata (1 : 1), natrijev lavrilsulfat, polisorbat 80, smukec (E553b), triacetin, emulzija simetikona.
Film coating: Polydextrose (E1200) Titanium dioxide (E171) Hypromellose (E464) Macrogol 4000
Filmska obloga: polidekstroza (E1200) titanov dioksid (E171) hipromeloza (E464) makrogol 4000
Film coating: Polyvinyl alcohol
makrogol 6000 hidrogenirano ricinusovo olje
Film coating; , composed of : polyvinyl alcohol – partly hydrolysed, macrogol / polyethylene glycol 3350, titanium dioxide (E171), talc, iron oxide red, iron oxide yellow, iron oxide black.
Obloga tablete: delno hidroliziran polivinilalkohol, makrogol/polietilenglikol 3350, titanov dioksid (E171), smukec, rdeči železov oksid, rumeni železov oksid, črni železov oksid.
Film coating;, composed of : polyvinyl alcohol – partly hydrolysed, macrogol / polyethylene glycol 3350, titanium dioxide (E171), talc, iron oxide red, iron oxide yellow, iron oxide black.
Obloga tablete: delno hidroliziran polivinilalkohol, makrogol/polietilenglikol 3350, titanov dioksid (E171), smukec, rdeči železov oksid, rumeni železov oksid, črni železov oksid.
Film-coat*: hydroxypropylcellulose, hypromellose, propylene glycol and titanium dioxide (E 171).
Filmska obloga*: hidroksipropilceluloza, hipromeloza, propilenglikol in titanov dioksid (E 171)
Film-coat: Hydroxypropylmethylcellulose Talc
Filmska obloga: hipromeloza smukec
Film-coat: Hydroxypropylmethylcellulose, Talc
Filmska obloga: hipromeloza smukec
Film-coat: hypromellose (E464), titanium dioxide (E171), polyethylene glycol, iron oxide yellow (E172) (for 0.5 mg tablets), polysorbate 80 (E433) and iron oxide red (E172) (for 2 mg tablets).
Filmska obloga: hipromeloza (E464), titanov dioksid (E171), polietilenglikol, rumeni železov oksid (E172) (za 0,5-mg tablete), polisorbat 80 (E433) in rdeči železov oksid (E172) (za 2-mg tablete).
Film-coat: hypromellose, titanium dioxide, black iron oxide (E172), macrogol, polysorbate 80
Filmska obloga: hipromeloza, titanov dioksid, črni železov oksid (E172), makrogol in polisorbat 80.
Film-coat: hypromellose, titanium dioxide, macrogol, polysorbate 80
Filmska obloga: hipromeloza, titanov dioksid, makrogol in polisorbat 80.
Film-coat: poly (vinyl alcohol), titanium dioxide, macrogol 3350, talc, soya lecithin, indigo carmine aluminium lake (E132).
Filmska obloga: polivinilalkohol, titanov dioksid, makrogol 3350, smukec, sojin lecitin, indigotin (E132).
Film-coat: polyvinyl alcohol, polyethylene glycol, talc, titanium dioxide (E171), colourants*
Filmska obloga: polivinilalkohol, polietilenglikol, smukec, titanov dioksid (E171), barvila
Film-coated
EU/1/11/706/019
Film-coated
filmsko obložena
Film-coated (tablet)
filmsko obložena (tableta)
Film-coated tablet
196 tablet 50x1 tableta
Film-coated tablet
filmska obložena tableta
Film-coated tablet
filmsko obložena
Film-coated tablet
Filmsko obložena tablet
Film-coated tablet
Filmsko obložena tableta Filmsko
Film-coated tablet
filmsko obložena tablete
Film-coated tablet
filmsko obložene
Film-coated tablet
Filmsko obložene tablet
Film-coated tablet
filmsko obložene tableta
Film-coated tablet
filmsko obložene tablete
Film-coated tablet
Filmsko obloћena tableta
Film-coated tablet
obložena tableta
Film-coated tablet
obložena tableta Filmsko
Film-coated tablet
Orodisperzibilna
Film-coated tablet
Pot uporabe
Film-coated tablet (tablet)
filmsko obložena tableta (tableta).
Film-coated tablet (tablet) Inlyta 1 mg film-coated tablets
filmsko obložena tableta (tableta)
Film-coated tablet (tablet).
ilmsko obložena tableta
Film-coated tablet (tablet).
ilmsko obložena tableta (tableta)
Film-coated tablet (tablet): The tablets are round, biconvex, pink, film-coated marked with a “60” above “T” on one side.
Filmsko obložena tableta (tableta): Tablete so okrogle, na obeh straneh izbočene, rožnate filmsko obložene tablete z oznako "60" nad "T" na eni strani.
Film-coated tablet (tablet): The tablets are round, biconvex, yellow, film-coated marked with a “90” above “T” on one side.
Filmsko obložena tableta (tableta): Tablete so okrogle, na obeh straneh izbočene, rumene filmsko obložene tablete z oznako "90" nad "T" na eni strani.
Film-coated tablet (tablets).
filmsko obložena tableta (tableta)
Film-coated tablet (tablets): STAYVEER 62.5 mg film-coated tablets
Filmsko obložena tableta (filmsko obložene tablete):
Film-coated tablet (tablets): Tracleer 62.5 mg film-coated tablets
Filmsko obložena tableta (filmsko obložene tablete):
Film-coated tablet 3 tablets
filmsko obložena tableta 3 tablete
Film-coated tablet 50 mg:
filmsko obložena tableta 50 mg:
Film-coated tablet [tablet].
filmsko obložena tableta [tableta]
Film-coated tablet contents: Microcrystalline cellulose Povidone K 25 Crospovidone
Filmsko obložena tableta vsebuje: mikrokristalna celuloza povidon K 25
Film-coated tablet Film-coated tablet
Filmsko obložena
Film-coated tablet Film-coated tablet
Filmsko obložena tableta
Film-coated tablet Film-coated tablet Film-coated tablet
filmsko obložena tableta
Film-coated tablet.
Filmsko obložene tablete
Film-coated tablet: yellow, capsule-shaped, film-coated tablet debossed with “Teva” on one side and “7541” on the other
Rumene filmsko obložene tablete, v obliki kapsule z oznako "Teva" na eni strani in številko "7541" na drugi strani.
Film-coated tablets
Filmsko obložene
Film-coated tablets
filmsko obloženih tablet
Film-coated tablets 1 film-coated tablet 3 film-coated tablets
1 filmsko obložena tableta 3 filmsko obložene tablete
Film-coated tablets 100 film-coated tablets
Filmsko obložene tablete 100 filmsko obloženih tablet
Film-coated tablets 42 film-coated tablets
filmsko obložene tablete 42 filmsko obloženih tablet
Film-coated tablets 60 film-coated tablets
filmsko obložene tablete 60 filmsko obloženih tablet
Film-coated tablets and powder for oral suspension
1 plastenka s 30 filmsko obloženimi tabletami,
Film-coated tablets and solution for infusion
Filmsko obložene tablete in raztopina za infundiranje
Film-coated tablets are blue, oblong and scored on one side and are supplied in packs of 20, 30, 50, 60 or 100 film-coated tablets or multipacks of 200 (2 packs of 100) film-coated tablets.
Filmsko obložene tablete so modre, podolgovate z zarezo na eni strani in pakirane po 20, 30, 50, 60 ali 100 filmsko obloženih tablet ali v večkratnem pakiranju po 200 (2 pakiranji po 100) filmsko obloženih tablet.
Film-coated tablets are light red coloured, oblong and scored on both sides and are supplied in packs of 20, 30, 50, 60, 80 or 100 film-coated tablets or multipacks of 200 (2 packs of 100) film-coated tablets.
Filmsko obložene tablete so svetlordeče, podolgovate z zarezo na obeh straneh in pakirane po 20, 30, 50, 60, 80 ali 100 filmsko obloženih tablet ali v večkratnem pakiranju po 200 (2 pakiranji po 100) filmsko obloženih tablet.
Film-coated tablets are white, oblong and scored on both sides and are supplied in packs of 10, 20, 30, 50, 60 or 100 film-coated tablets or multipacks of 200 (2 packs of 100) film-coated tablets.
Filmsko obložene tablete so bele, podolgovate z zarezo na obeh straneh in pakirane po 10, 20, 30, 50, 60 ali 100 filmsko obloženih tablet ali v večkratnem pakiranju po 200 (2 pakiranji po 100) filmsko obloženih tablet.
Film-coated tablets are yellow, oval and scored on one side and are supplied in packs of 10, 20, 30, 50, 60 or 100 film-coated tablets or multipacks of 120 (2 packs of 60) or 200 (2 packs of 100) film- coated tablets.
Filmsko obložene tablete so rumene, ovalne z zarezo na eni strani in pakirane po 10, 20, 30, 50, 60 ali 100 filmsko obloženih tablet ali v večkratnem pakiranju po 120 (2 pakiranji po 60) ali 200 (2 pakiranji po 100) filmsko obloženih tablet.
Film-coated tablets Treatment initiation pack
filmsko obložene tablete pakiranje za začetek zdravljenja
Film-coated tablets.
filmsko obložena tableta
Film-coated tablets.
filmsko obložene tablete
Film-coated tablets.42 film-coated tablets.
Filmsko obložene tablete.
Film-coated, dark red, oval shaped tablet, mentioning T on one side, 800 on the other side.
Filmsko obložena, temno rdeča ovalna tableta z oznako T na eni strani in 800 na drugi.
Film-coated, light orange, oval shaped tablet, mentioning TMC on one side, 400MG on the other side.
Filmsko obložena, svetlo oranžna ovalna tableta z oznako TMC na eni strani in 400MG na drugi.
Film-coated, orange, oval shaped tablet, mentioning TMC on one side, 600MG on the other side.
Filmsko obložena, oranžna ovalna tableta z oznako TMC na eni strani in 600MG na drugi.
Film-coated, orange, oval shaped tablet, mentioning TMC114 on one side, 300MG on the other side.
Filmsko obložena, oranžna ovalna tableta z oznako TMC114 na eni strani in 300MG na drugi.
Film-coated, white, caplet shaped tablet, mentioning TMC on one side, 75 on the other side.
Filmsko obložena, bela ovalna tableta z oznako TMC na eni strani in 75 na drugi.
Film-coated, white, oval shaped tablet, mentioning TMC on one side, 150 on the other side.
Filmsko obložena, bela ovalna tableta z oznako TMC na eni strani in 150 na drugi.
Film-coating - hypromellose (hydroxypropyl methyl cellulose, E464), titanium dioxide (E171), talc (E553b), triacetin (E1518), red iron oxide (E172)
Filmska obloga - hipromeloza (hidroksipropilmetil celuloza, E464), titanov dioksid (E171), smukec (E553b), triacetin (E1518) in rdeči železov oksid (E172).
Film-coating Ethylcellulose Hypromellose Macrogol 8000 Triethyl citrate Titanium dioxide Talc
Filmska obloga etilceluloza hipromeloza makrogol 8000 trietil citrat titanov dioksid smukec
Film-coating for 150 mg/12.5 mg strength: Hypromellose
Filmska obloga za jakosti 150 mg/12,5 mg: hipromeloza
Film-coating for 300 mg/12.5 mg strength: Hypromellose
Filmska obloga za jakosti za 300 mg/12,5 mg: hipromeloza
Film-coating Hypromellose (E464) Iron oxide red (E172) Lactose monohydrate Triacetin (E1518) Titanium dioxide (E171)
filmska obloga hipromeloza (E464) rdeči železov oksid (E172) laktoza monohidrat triacetin (E1518) titanov dioksid (E171)
Film-coating Hypromellose Titanium dioxide Lactose monohydrate Triacetin
Filmska obloga hipromeloza titanov dioksid laktoza monohidrat triacetin
Film-coating Hypromellose Titanium dioxide Macrogol 400
Filmska obloga hipromeloza titanov dioksid makrogol 400
Film-coating Lecithin (soybeans) Poly(vinyl alcohol) Talc
Filmska obloga lecitin (sojina zrna)
Film-coating of the 150 mg tablets: hypromellose, titanium dioxide (E171), yellow iron oxide, red iron oxide (E172), talc.
Filmska obloga 150 mg tablet: hipromeloza, titanov dioksid (E171), rumeni železov oksid, rdeči železov oksid (E172), smukec.
Film-coating of the 300 mg tablets: hypromellose, titanium dioxide (E171), talc.
Filmska obloga 300 mg tablet: hipromeloza, titanov dioksid (E171), smukec.
Film-coating of the 500 mg tablets: hypromellose, titanium dioxide (E171), yellow iron oxide, red iron oxide (E172), talc.
Filmska obloga 500 mg tablet: hipromeloza, titanov dioksid (E171), rumeni železov oksid, rdeči železov oksid (E172), smukec.
Film-coating:
Natrijev karboksimetilškrob, vrsta A
Film-coating: hydroxypropylcellulose (E463), titanium dioxide (E171), red iron oxide (E172), talc and propylene glycol.
Obloga tablete: hidroksipropilceluloza (E463), titanov dioksid (E171), rdeči železov oksid (E172), smukec ter propilenglikol.
Film-coating: hypromellose (E464), iron oxide red (E172), macrogol/PEG 4000, titanium dioxide (E171), colourants*.
Filmska obloga: hipromeloza (E464), rdeči železov oksid (E172), makrogol /PEG 4000 , titanov dioksid (E171), barvila*.